Clinical Trials Using Oncolytic HSV1716
Clinical trials are research studies that involve people. The clinical trials on this list are studying Oncolytic HSV1716. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Oncolytic HSV1716 in Treating Patients with Refractory Non-Central Nervous System Solid Tumors
This phase I trial studies the side effects and best dose of oncolytic simplexvirus (HSV)1716 in treating patients with non-central nervous system solid tumors that has not responded to previous treatment. A virus, called oncolytic HSV1716, which has been changed in a certain way, may be able to kill tumor cells without damaging normal cells.
Location: 2 locations